Sujatha Gurunathan

Blog Post

Clinical Trial Alert: Phase 3 Study of ALXN1720 in Adults with Generalized Myasthenia Gravis (gMG)

By Sujatha Gurunathan | May 13, 2024
Ribonucleic acid strands consisting of nucleotides important for protein bio-synthesis - 3d illustration
Blog Post

Simply Stated: Updates in SELENON-Related Myopathy

By Sujatha Gurunathan | May 7, 2024
Blog Post

Clinical Study Alert: Phase 2 Study of Vamorolone in Adults with BMD

By Sujatha Gurunathan | April 2, 2024
Blog Post

Clinical Study Alert: Phase 2 Study of Brogidirsen in Boys with DMD

By Sujatha Gurunathan | March 29, 2024
Blog Post

Clinical Study Alert: A Phase 1/2 Study of Safety and Efficacy of LX2006 Gene Therapy in Adults with Cardiomyopathy Associated with Friedreich Ataxia

By Sujatha Gurunathan | March 25, 2024
The key pathologic change of the muscular dystrophy is the myonecrosis. At an early phase, necrotic fibers appear swollen, homogeneous and deeply eosinophilic. This disease is caused by mutations of dystrophin, the largest known human gene, located on chromosome Xq21.
Blog Post

Simply Stated: Updates in LAMA2 Muscular Dystrophy

By Sujatha Gurunathan | February 20, 2024
Blog Post

Research Study Alert: Genome-Wide Association Study in People with MuSK MG

By Sujatha Gurunathan | February 5, 2024
Blog Post

Research Study Alert: Noninterventional Study in People with DMD and BMD

By Sujatha Gurunathan | January 11, 2024
Color image of a real life young physically impaired ALS patient computer gaming with the help of his electronic wheelchair.
Blog Post

Simply Stated: Updates in Collagen VI-Related Dystrophy

By Sujatha Gurunathan | January 6, 2024
Mitochondrion in cell cross section
Blog Post

Simply Stated: Research Updates in Leigh Syndrome

By Sujatha Gurunathan | December 6, 2023